Compounds for inhibiting NLRP3 and uses thereof
US12351578B2 · kind B2 · utility
0Cited by
63References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2022 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | Oct 26, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to inhibitors of NLRP3 useful in the treatment of diseases and disorders inhibited by said protein and having the Formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.